This protocol covers neuron and neurosphere dissociation — taking neural tissue or free-floating neurospheres to a single-cell suspension without destroying the cells you need. Neural preparations fail differently from epithelial ones: post-mitotic neurons extend processes that shear off, neurospheres tolerate complete dissociation badly, and several of the surface antigens used to sort neural populations are destroyed by the very enzymes that dissociate the tissue fastest. The protocol is written reagent-neutral, and it states plainly which parts rest on published data and which are starting points you must titrate.
The core problem. A neuron’s value is in its processes, and its processes are the first thing a pipette destroys. Most damage in neural dissociation comes from trituration, not from the enzyme — which is why the correct instinct is to use the enzyme to do more of the work and the pipette to do less.
Decide the Endpoint Before You Start
The right degree of dissociation depends entirely on what happens next.
| Downstream use | What actually matters | Protocol consequence |
|---|---|---|
| Neurosphere passaging / expansion | Regrowth and sphere-forming efficiency | Do not go to true single cells unless the assay requires it. Mechanical passaging that preserves cell–cell contact is a legitimate alternative. |
| Clonal neurosphere assay | Genuine single cells, verified | Complete dissociation and a low plating density are mandatory; a doublet reads as a clone and inflates your frequency. |
| Flow cytometry / sorting (CD133, CD15, CD24, A2B5, PSA-NCAM) | Antigen survival, not just viability | Enzyme choice decides which markers are still detectable. See the antigen section below. |
| Plating primary neurons | Intact membranes and attachment competence | Minimise trituration passes; accept incomplete yield rather than shearing the population. |
| Single-cell RNA-seq | Viability, debris, and the transcriptional state you induced | The dissociation itself alters the transcriptome; keep the warm window short and identical across arms. |
Materials and Reagents
- Neurospheres in suspension culture, or neural tissue dissected into ice-cold, Ca2+/Mg2+-free HBSS
- Dissociation reagent: papain with its matched inhibitor, a recombinant trypsin-like enzyme, or a purified collagenase/neutral protease cocktail — see the antigen section before choosing
- DNase I, typically 10–100 µg/mL final, present from the start of the enzymatic step
- Ovomucoid/albumin inhibitor if using papain; for dilution-quenched recombinant enzymes, plain medium is sufficient
- Basal neural medium (Neurobasal-type or DMEM/F12) with the supplements your line requires; EGF, bFGF and heparin for neurosphere expansion
- Fire-polished glass Pasteur pipettes of decreasing bore, or pre-wetted P1000 and wide-bore tips
- 40 µm cell strainers, pre-wetted; optional density gradient medium for debris and myelin removal
- Poly-L-lysine- (and where required laminin-) coated substrate for plating neurons
- Refrigerated benchtop centrifuge, ice bucket, 0.4% trypan blue and a counter
Every concentration and time below is a starting value. Neural preparations vary enormously with species, region, developmental age and days in culture. Take the numbers here as a place to begin a titration on your own material, not as a specification.
Protocol A — Passaging Neurospheres
Neurospheres are free-floating clonal aggregates that arise when EGF-responsive cells from the central nervous system proliferate in serum-free medium, generating both neurons and astrocytes on differentiation (Reynolds & Weiss, Science 1992). Reproducible neurosphere culture depends more on technique than on reagent choice (Azari et al., J Vis Exp 2011).
- Collect the spheres gently. Transfer the suspension to a tube and either let the spheres settle by gravity for 5 minutes or centrifuge at 100–150 × g for 5 minutes. Spheres are light; a hard spin packs them and they dissociate unevenly afterwards.
- Wash once. Aspirate the conditioned medium and resuspend in Ca2+/Mg2+-free PBS or basal medium. Divalent cations support the adhesion you are trying to break.
- Add the dissociation reagent with DNase I. Use a small volume — enough to keep the spheres freely suspended and no more. Pre-warm the reagent.
- Incubate short and check. At 37 °C, check every 3–5 minutes; most neurosphere preparations need only 5–10 minutes in total. Large or old spheres with necrotic cores need less enzyme and more care, not more time.
- Triturate deliberately. 8–10 slow passes with a pre-wetted P1000, held against the tube wall so no air is drawn in. Foam means lysis. Count the passes out loud and keep the count constant between passages — an uncontrolled trituration is the single biggest source of passage-to-passage variability in neurosphere culture.
- Quench. Add at least twice the enzyme volume of medium. Papain needs its ovomucoid/albumin inhibitor; a dilution-quenched recombinant enzyme needs only medium.
- Wash and count. Centrifuge at 200–300 × g for 5 minutes, resuspend in complete expansion medium, count with trypan blue, and inspect for doublets and debris.
- Replate at a defined density. Sphere formation is density-dependent, so plating density is a variable to control, not a convenience. For a clonal assay, plate low enough that spheres cannot arise by aggregation.
The alternative worth knowing: don’t dissociate at all
For expansion — as opposed to assay — complete dissociation into single cells can push several stem and progenitor types toward differentiation or early senescence. An automated mechanical passaging method (“chopping”) avoids chemical or enzymatic dissociation entirely by passing a sterile blade through settled spheres, keeping cell–cell contact intact; it has been used for fetal brain-derived progenitors and for neural stem cells derived from embryonic and induced pluripotent stem cells, and has been operated under current good manufacturing practice for clinical-grade production (Shelley et al., J Vis Exp 2014). If your reason for dissociating is simply “it is passage day”, this is the gentler route.
Protocol B — Neural Tissue to a Single-Cell Suspension
This branch applies to primary brain or spinal cord tissue and to iPSC-derived neural cultures being taken to single cells.
- Dissect into ice-cold Ca2+/Mg2+-free buffer and keep it cold until the enzyme goes in. Cold is free protection; every warm minute before the enzymatic step is a wasted one.
- Cut to roughly 1 mm pieces. Enzyme access, not enzyme concentration, is usually the limiting factor.
- Digest with DNase I present from the start. Papain with EDTA is the classical choice for central nervous system tissue and is used in published adult rat and human spinal cord neural stem/progenitor protocols (Mothe & Tator, J Vis Exp 2015); papain-based digestion is also standard for early postnatal mouse hippocampal and cortical pyramidal neurons (Beaudoin et al., Nat Protoc 2012). Check the tissue every 5 minutes and stop when the pieces look softened and fuzzy at the edges — not when they have disappeared.
- Stop the enzyme properly. Papain requires its ovomucoid/albumin inhibitor; carrying active papain into the plating step is a common and avoidable cause of poor attachment. Recombinant trypsin-like enzymes designed for dilution quenching need only medium.
- Triturate with decreasing bore. Fire-polished Pasteur pipettes, 8–10 passes each, largest bore first. Let the undissociated fragments settle for 2 minutes, take the cloudy supernatant to a fresh tube, and re-triturate only the fragments. Repeatedly triturating the whole preparation destroys the cells you already released.
- Remove debris. A discontinuous density gradient separates viable cells from myelin and cell fragments and is worth the extra 20 minutes for adult tissue, where debris otherwise dominates (Mothe & Tator 2015).
- Strain at 40 µm, pre-wetted, and rinse the mesh to recover retained cells.
- Pellet at 200–300 × g, 5 minutes, 4 °C, and resuspend in the buffer the next step requires — plating medium, staining buffer, or a cold BSA-containing buffer for droplet sequencing.
- Count and plate promptly. Dissociated neurons deteriorate quickly in suspension. Plate onto poly-L-lysine (with laminin where your protocol calls for it) and move on without a pause.
Enzyme Choice Decides Which Neural Markers Survive
If you plan to sort or phenotype the cells, the enzyme is part of the assay. A systematic comparison of dissociation methods on mouse central nervous system tissue and human central nervous system tumour tissue found (Panchision et al., Stem Cells 2007):
- Non-enzymatic dissociation yielded poor viability, while papain, a purified trypsin replacement (TrypLE™) and two purified collagenase/neutral protease cocktails (Liberase-1 or Accutase®) each dissociated fetal and postnatal tissue efficiently.
- Papain most aggressively reduced antigenicity for mouse and human CD24.
- On human central nervous system tumour cells, CD133 expression remained highest after Liberase-1 and was lowest after papain or Accutase®; Liberase-1 digestion allowed magnetic sorting for CD133 without an antigen re-expression recovery period.
- The authors concluded that Liberase-1 and the purified trypsin replacement gave the best balance of dissociation efficiency, viability and antigen retention.
- A practical consequence they demonstrate: discriminating fetal mouse multipotent stem cells from neuronal progenitors using CD133/CD24 or CD15/CD24 is not possible after papain treatment.
The lesson is not that papain is a bad enzyme — it is excellent for viable neurons. The lesson is that the enzyme that gives you the healthiest neurons may be the one that erases the marker you intended to sort on, so the enzyme must be chosen against the readout. Where an antigen is cleaved rather than lost, a short recovery period in culture before staining usually restores it; where you cannot afford that delay, choose the enzyme that leaves the epitope intact.
These findings describe the specific reagents those authors tested. They are not evidence about any other product, and we do not extend them.
Troubleshooting
| Problem | Likely cause | What to do |
|---|---|---|
| Low viability, lots of debris | Over-trituration, or trituration before the enzyme has done its work | Fewer, slower passes; extend the enzymatic step slightly instead; settle-and-decant rather than re-triturating everything |
| Stringy, viscous suspension | Free DNA from lysed cells | Include DNase I from the start of the enzymatic step rather than as a rescue, and reduce shear |
| Spheres do not re-form after passaging | Over-digestion, plating density too low, or growth factors exhausted | Shorten the enzymatic step, plate at a defined higher density, and refresh EGF/bFGF; consider mechanical passaging instead (Shelley 2014) |
| Neurons attach but do not extend processes | Residual active protease carried into plating, or shear damage | Confirm the quench is complete and the wash adequate; reduce trituration passes |
| Surface marker missing in flow | Epitope cleaved by the enzyme | Allow a recovery period before staining, or switch to an enzyme shown to retain that antigen (Panchision 2007) |
| Myelin and fragments dominate the preparation | Adult tissue without a debris-removal step | Add a density gradient separation before straining |
| Stress genes dominate scRNA-seq clustering | Warm enzymatic digestion artefact | Shorten the warm window, keep every other step cold, hold the method identical across arms, and score the published stress gene set (O’Flanagan 2019) |
| Clonal frequency looks implausibly high | Doublets plated as “single cells”, or spheres forming by aggregation | Verify single cells microscopically after straining and reduce plating density |
Reagent Choice, and What the Data Covers
Laboratories running xeno-free or clinical-track neural work replace animal-derived proteases with recombinant, animal-origin-free enzymes to remove TSE/BSE and adventitious-agent risk and to reduce lot-to-lot variability. CellTrypase from Kerry (formerly c-LEcta) is one option in that class: a recombinant trypsin-like serine protease from a Fusarium oxysporum gene expressed in a Bacillus sp. host, ~22 kDa, cleaving after lysine and arginine; ≥95% purity by HPLC; formulated in PBS with 1.1 mM EDTA and sterile filtered; pH 7.1–7.6 and 270–320 mOsm/kg; endotoxin ≤1 EU/mL at 1× and ≤10 EU/mL at 10×; mycoplasma negative; sterility per Ph. Eur. 2.6.1 / USP <71>. It is quenched by dilution in buffer or medium, so no inhibitor enters the preparation, and it is stable for at least 21 months at 2–8 °C. R&D grade is manufactured under ISO 9001:2015 and GMP grade under EXCiPACT® GMP/GDP, from the same manufacturer.
What has been measured — and what has not
The dissociation table in the product information sheet covers four adherent monolayer lines:
| Cell line | Release time (min:s) | Viability | Yield |
|---|---|---|---|
| CHO-K1 | 2:25 | 98% | 106% |
| HEK 293 | 2:27 | 95% | 100% |
| Vero | 4:07 | 99% | 103% |
| MDCK | 23:32 | 99% | 102% |
Source: CellTrypase Product Information Sheet v4.0 (Kerry, 18 August 2026). MDCK is shown at 23:32 — roughly ten times the CHO-K1 incubation at the same viability, because junctional architecture sets the required exposure.
Kerry has also published five-passage data (P0–P4) for those four lines covering viability, relative yield and population doubling time, with doubling times equal to or shorter than the industry-standard control; and human iPSC data — 5 minutes to a single-cell suspension against 7 minutes for the industry-standard control at 94% viability for both, 99% relative yield and residual aggregates below 5% in 2D, and about 10 minutes for both enzymes in 3D aggregates at 87% versus 85% viability, 104% relative yield and 12% versus 16% residual aggregates.
Source: Kerry scientific poster #11462, “Advancing cell dissociation in bioprocessing with CellTrypase” (February 2026); n = 3 technical replicates, mean ± SD.
None of that is neural data. There is no published release time, viability, yield, recovery, neurite integrity, sphere-forming efficiency or marker-retention figure for neurons, neurospheres, neural stem or progenitor cells, or iPSC-derived neural cultures. The manufacturer names neural applications among the intended uses — an intention is not a measurement, and we will not put numbers on that gap. Anyone considering the switch should qualify it side by side against their current enzyme, on their own preparation, with their own endpoints: time to dissociation, viability, debris, sphere-forming or plating efficiency, and the specific antigens they sort on.
Free 100 mL sample for qualification
BioHippo supplies a free 100 mL sample of CellTrypase for side-by-side qualification — one per laboratory, while supplies last. For a neural comparison, the endpoints worth recording are time to dissociation, trypan blue viability, debris load after straining, sphere-forming or plating efficiency, and staining intensity for the markers you sort on. Request a free sample →
Related reading: the CellTrypase cell dissociation protocol, the CellTrypase specifications guide, and the organoid dissociation protocol for the three-dimensional equivalent of this workflow.
Frequently Asked Questions
Papain or trypsin for neurons?
Papain is the classical choice for viable central nervous system neurons and is used in standard published protocols. The caveat is antigenic: papain most aggressively reduced CD24 antigenicity, and CD133 was lowest after papain, in a systematic comparison of dissociation methods (Panchision et al. 2007). Choose the enzyme against your readout, not by habit.
How long should a neurosphere dissociation take?
Most preparations need only 5–10 minutes at 37 °C with a microscope check every 3–5 minutes, but treat that as a range to titrate on your own spheres. Sphere size, passage number and days in culture all change it.
Do I have to dissociate neurospheres to single cells?
Only if the assay requires it. For routine expansion, mechanical passaging that keeps cell–cell contact intact avoids the differentiation and early-senescence risk that complete dissociation carries, and has been run under GMP for clinical-grade production (Shelley et al. 2014). For a clonal assay, genuine single cells are non-negotiable.
Why is my suspension stringy?
Free DNA from lysed cells. Include DNase I from the beginning of the enzymatic step rather than adding it as a rescue, and take the stringiness as a signal that your trituration is too forceful.
How many trituration passes are safe?
Eight to ten slow passes per bore size, with the tip against the tube wall and no air drawn in. Foam means lysis. Settle the undissociated fragments and re-triturate only those, rather than passing the whole preparation again.
Is there performance data for CellTrypase on neurons or neurospheres?
No. Published comparative data covers CHO-K1, HEK 293, MDCK, Vero and human iPSC in 2D and 3D. Neural applications are named by the manufacturer as intended uses with no performance figures attached, so we quote none. The free 100 mL sample exists so you can generate that comparison on your own preparation.
Does dissociation change my single-cell RNA-seq data?
Yes. Warm enzymatic digestion induces a conserved heat-shock and stress-response signature that cold-active digestion minimises (O’Flanagan et al. 2019), and the induction is not uniform across cell types (van den Brink et al. 2017). Keep the warm window short and identical across every arm of a comparison.
Reagents and Support
Browse dissociation enzymes in the BioHippo enzymes collection and neural models in the cell lines collection. For help designing a dissociation comparison on your own neural preparation, ask a scientist.
For research use only; not for use in diagnostic or therapeutic procedures. The R&D grade of CellTrypase is supplied for research use only. TrypLE™ is a trademark of Thermo Fisher Scientific; Accutase® and Liberase™ are trademarks of their respective owners; all are referred to here for identification and comparison only, and BioHippo is not affiliated with, endorsed by, or sponsored by those companies. Published findings are attributed to their authors and apply to the reagents, tissues and species those authors tested; they are not claims about CellTrypase. CellTrypase performance figures are attributed to the CellTrypase Product Information Sheet v4.0 (Kerry, 18 August 2026) for the four-cell-line table and to Kerry scientific poster #11462 (February 2026) for the five-passage and human iPSC data; they apply only to the cell types named, and no performance data is claimed for neurons, neurospheres, neural stem or progenitor cells, or any other cell type. Incubation times, enzyme concentrations, trituration passes and centrifugation settings given here are starting values to be confirmed on your own preparation, not specifications. Peer-reviewed sources are cited inline and indexed in PubMed.